Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR, Billions.
The item "Deferred-Long-Term-Liabilities" stands at 6.23 Billion Euros as of 12/31/2022, the lowest value since 03/31/2021.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -19.46 percent compared to the value the year prior.
The 1 year change in percent is -19.46.
The 3 year change in percent is 166.75.
The 5 year change in percent is 322.10.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Deferred Long Term Liabilities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Deferred Long Term Liabilities | 486,508,953,600.00 |
![]() | AbbVie Inc - Deferred Long Term Liabilities | 399,570,305,024.00 |
![]() | Roche Holding AG - Deferred Long Term Liabilities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Deferred Long Term Liabilities | 280,205,508,085.11 |